PASO Patient Access Solutions Inc (CE)

Patient Access Solutions, Inc. (PINKSHEETS: PASO), a leading provider of information technology solutions for the healthcare industry announced today a partnership with iMedicor (OTCBB: VMCI). The partnership will provide a complementary synergy of combined products and services that will enable enhanced information exchange capabilities by integrating the iMedicor portal with Patient Access Solution's digital pen technology for the home healthcare industry and robust HIPAA transaction processing and reporting platform. In addition, Patient Access Solution's 4000+ users will have access to iMedicor's ClearLobby platform that will provide informative, product specific content on new drugs and medical devices enabling users to directly communicate electronically with the manufacturers to order samples, ask questions and set up onsite meetings. ClearLobby establishes an additional revenue driver and value added solution to users by providing access to the recently announced National health information exchange and the National Healthcare Communications Network (NHCN).

Both companies are pleased to announce the Alliance's first opportunity, a 5,000 member healthcare provider group, has entered its implementation phase and scheduled to be live by Q4, 2010. Conservative projections estimate recurring gross annual revenue of over $1,000,000 throughout the PASO user base.

iMedicor's pharma marketing platform, "ClearLobby," offers the first of its kind physician / pharma electronic communication system resulting in interactions that are much more meaningful and efficient. ClearLobby changes the dynamic of these relationships by placing control squarely in the hands of the physician. At the same time, the interaction between the physician and the pharma becomes more cost effective because ClearLobby is able to distribute critical product information and samples directly to the targeted user base.

"We are excited about the strategic partnership we've developed with iMedicor. Their ClearLobby solution interfaced with our technology will provide the healthcare industry with a secure, robust, dynamic information and messaging platform. Being able to develop a mutually beneficial recurring revenue business model creates a win-win for both organizations," said CEO Bruce Weitzberg.

"This alliance is another major step in launching our National Health Information Exchange and will go a long way in supporting and making a reality of the National Healthcare Communication Network," said Fred Zolla, iMedicor's CEO. "This is a great opportunity for two up and coming companies."

About iMedicor

iMedicor is the only HIPAA-compliant solution for interoperable medical information transfer that is offered to healthcare providers and patients. The iMedicor portal also enables doctors, administrators and other qualified healthcare workers to send and receive medical records, files and images in a secure, HIPAA compliant environment; allows disparate EMR (electronic medical record) systems to communicate, collaborate and exchange records in real time; and allows pharmaceutical companies to deliver customized marketing programs to healthcare providers nationwide in a highly targeted, cost-effective and non-intrusive manner. More information on iMedicor is available at www.imedicor.com.

About Patient Access Solutions, Inc.

Patient Access Solutions, Inc. (PAS) is a Healthcare Solutions Company which has created a formidable array of technology, resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare information technology environment. The Company's products are designed to allow health care providers an easy migration to the EMR environment. Among these products are D-PAS, which is a state-of-the-art digital pen and paper technology based on Anoto technology, used to capture hand written information into digital forms and EMR systems and PAS Data Center, which is a terminal solution that allows health care providers to quickly and easily determine benefit eligibility. More information on Patient Access Solutions, Inc. and its products can be viewed at www.pashealth.com.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things, the following: general economic and business conditions; competition; unexpected changes in technologies and technological advances; ability to commercialize and manufacture products; results of experimental studies; research and development activities; changes in, or failure to comply with, governmental regulations; and the ability to obtain adequate financing in the future. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of Patient Access Solutions Inc. Securities and Exchange Commission filings available at http://www.sec.gov.

Investor and Media Contact: Craig StoutChief Operating Officer (845) 356-5211 cstout@vemics.com